AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30841807 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% BAC
Number of subjects: 108
Study 30841807 — intervention group
Group type: COMPARATOR
Intervention: 0.10% BAC
Number of subjects: 108
Study 30841807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 27720142 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure telemonitoring and pharmacist management
Number of subjects: 351
Study 27720142 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 351
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access in high-volume centers
Number of subjects: 7021
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access in intermediate-volume centers
Number of subjects: 7021
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access in low-volume centers
Number of subjects: 7021
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall percutaneous coronary intervention volume
Number of subjects: 7021
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial center volume
Number of subjects: 7021
Study 24269362 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral center volume
Number of subjects: 7021
Study 22717726 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 45 mg kg(‐1) in 100 ml of isotonic saline
Number of subjects: 60
Study 22717726 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental care during pregnancy
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived oral health
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Importance of healthy teeth for baby vs self
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival bleeding before and during pregnancy
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost as a deterrent for dental visits
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental care visits for gingival bleeding during pregnancy
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of oral health
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship between gingival bleeding and perceived oral health
Number of subjects: 649
Study 20047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors related to gingival bleeding during pregnancy
Number of subjects: 649
Study 18655982 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ SN60WF IOL
Number of subjects: 65
Study 18655982 — intervention group
Group type: COMPARATOR
Intervention: AcrySof SA60AT IOL
Number of subjects: 65
Study 15994252 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 18
Study 15994252 — intervention group
Group type: COMPARATOR
Intervention: Control (no CPAP treatment)
Number of subjects: 18
Study 12905750 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g propacetamol in 100 ml normal saline intravenously
Number of subjects: 40
Study 12905750 — intervention group
Group type: COMPARATOR
Intervention: 50 mg dolantin intramuscularly
Number of subjects: 40
Study 12905750 — intervention group
Group type: COMPARATOR
Intervention: 1.6 g mannitose in 100 ml NS intravenously as placebo control to propacetamol
Number of subjects: 40
Study 10227267 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated trivalent influenza vaccine
Number of subjects: 24
Study 10227267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8913990 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (moderate dose of alcohol 0.56 g/kg)
Number of subjects: 66
Study 8913990 — intervention group
Group type: EXPERIMENTAL
Intervention: Group AC (moderate dose of alcohol 0.56 g/kg with expectancy challenge)
Number of subjects: 66
Study 8913990 — intervention group
Group type: COMPARATOR
Intervention: Group NT (no treatment, no alcohol)
Number of subjects: 66
Study 1487552 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrazinoylguanidine (PZG) 600 mg twice daily for 4 weeks
Number of subjects: 12
Study 3897960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (30 mg/kg intravenously over 30 minutes, one hour before surgery, and 30 mg/kg over one hour, 3 hours, and 6 hours after initial infusion)
Number of subjects: 23
Study 3897960 — intervention group
Group type: COMPARATOR
Intervention: Control (no routine intra or postoperative antibiotics)
Number of subjects: 23
Study 3897960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 23
Study 3897960 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 23
Study 30577943 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for depressed adolescents (IPT‐A) with a week 4 decision point
Number of subjects: 40
Study 30577943 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal psychotherapy for depressed adolescents (IPT‐A) with a week 8 decision point
Number of subjects: 40
Study 30577943 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased frequency of IPT‐A (twice per week)
Number of subjects: 40
Study 30577943 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of fluoxetine
Number of subjects: 40
Study 29388275 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 min·wk‐1 of aerobic exercise (low-dose)
Number of subjects: 39
Study 29388275 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 min·wk‐1 of aerobic exercise (high-dose)
Number of subjects: 39
Study 29388275 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 39
Study 25218903 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone preconditioning (Major Auto-Hemotherapy, 35µg/ml)
Number of subjects: 50
Study 25218903 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=50, age and gender matched)
Number of subjects: 50
Study 22151583 — intervention group
Group type: EXPERIMENTAL
Intervention: Timeline follow-back (TLFB) self-report of cannabis use
Number of subjects: 103
Study 22151583 — intervention group
Group type: EXPERIMENTAL
Intervention: Timeline follow-back (TLFB) self-report of cannabis use with 19 days cut-off
Number of subjects: 103
Study 22945778 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% gel
Number of subjects: 96
Study 22945778 — intervention group
Group type: COMPARATOR
Intervention: Lubricant gel
Number of subjects: 96
Study 22945778 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 96
Study 16636770 — intervention group
Group type: EXPERIMENTAL
Intervention: Kneeling position
Number of subjects: 271
Study 16636770 — intervention group
Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 271
Study 15929619 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo Off Line program
Number of subjects: 56
Study 15929619 — intervention group
Group type: COMPARATOR
Intervention: Standard videotape echocardiography
Number of subjects: 56
Study 11899180 — intervention group
Group type: EXPERIMENTAL
Intervention: Stented C‐E pericardial valve (CE)
Number of subjects: 99
Study 11899180 — intervention group
Group type: EXPERIMENTAL
Intervention: Toronto Stentless Porcine valve (SPV)
Number of subjects: 99
Study 11899180 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CE and SPV)
Number of subjects: 99
Study 10450276 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabenazine (mean dose = 57.9 mg/day, duration = mean 20.3 weeks)
Number of subjects: 20
Study 10450276 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabenazine (mean dose = 57.9 mg/day)
Number of subjects: 20
Study 7771886 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoue technique
Number of subjects: 262
Study 7771886 — intervention group
Group type: EXPERIMENTAL
Intervention: Double balloon technique
Number of subjects: 262
Study 7771886 — intervention group
Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 262
Study 2589137 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence from smoking for 24 hours
Number of subjects: 16
Study 2589137 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking
Number of subjects: 16
Study 2589137 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 16
Study 31302276 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PVP) in improved prone position (group A)
Number of subjects: 60
Study 31302276 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous vertebroplasty (PVP) in right lateral position (group B)
Number of subjects: 60
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) assessed by family members in the Netherlands
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) assessed by family members in the United States
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) assessed by nurses in the Netherlands
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) assessed by nurses in the United States
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) total score assessed by nurses in the Netherlands
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Dying and Death (QODD) total score assessed by nurses in the United States
Number of subjects: 446
Study 27660153 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of nurse-assessed QODD items between the Netherlands and the United States
Number of subjects: 446
Study 25293586 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss Maintenance (LM)
Number of subjects: 138
Study 25293586 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss Regain (LR)
Number of subjects: 138
Study 25293586 — intervention group
Group type: COMPARATOR
Intervention: Weight Stable (WS)
Number of subjects: 138
Study 24474991 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 320
Study 21465003 — intervention group
Group type: EXPERIMENTAL
Intervention: Light cola (EL)
Number of subjects: 10
Study 21465003 — intervention group
Group type: EXPERIMENTAL
Intervention: Light cola plus abrasion (EAL)
Number of subjects: 10
Study 21465003 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cola (ER)
Number of subjects: 10
Study 21465003 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cola plus abrasion (EAR)
Number of subjects: 10
Study 17934156 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT) delivered through the V.A.C. Therapy System (n = 77)
Number of subjects: 162
Study 17934156 — intervention group
Group type: COMPARATOR
Intervention: Standard moist wound therapy (MWT) (n = 85)
Number of subjects: 162
Study 17934156 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 162
Study 16503775 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporin 0.05%
Number of subjects: 0
Study 16503775 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin 0.3%/dexamethasone 0.1%
Number of subjects: 0
Study 14517597 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral risedronate 5 mg/day for 12 months
Number of subjects: 34
Study 14517597 — intervention group
Group type: COMPARATOR
Intervention: No risedronate (Control group)
Number of subjects: 34
Study 10711621 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) with a poly(lactic acid)‐based bioabsorbable membrane
Number of subjects: 12
Study 10711621 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 12
Study 9353575 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie/low-fat diet (LCFD)
Number of subjects: 8
Study 9353575 — intervention group
Group type: COMPARATOR
Intervention: High-calorie/high-fat diet (HCFD)
Number of subjects: 8
Study 8401337 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme Allergo‐Sorbent Testing (EAST)
Number of subjects: 97
Study 8401337 — intervention group
Group type: COMPARATOR
Intervention: Skin tests
Number of subjects: 97
Study 3018068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (30 ml of 2.39 M, 6.17 g)
Number of subjects: 10
Study 3018068 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-magnesium antacid (30 ml equivalent to 71.7 mmol of in vitro buffer)
Number of subjects: 10
Study 3018068 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10
Study 31414887 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation (CCRG) using ERICA software
Number of subjects: 40
Study 31414887 — intervention group
Group type: COMPARATOR
Intervention: Traditional cognitive rehabilitation (TCRG)
Number of subjects: 40
Study 30096139 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART universal-test-and-treat (UTT) package delivered by community HIV care providers (CHiPs)
Number of subjects: 120272
Study 26250076 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum intervention (test group)
Number of subjects: 254
Study 26250076 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 254
Study 26250076 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 254
Study 24256079 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate surgery
Number of subjects: 39
Study 24256079 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 39
Study 22375574 — intervention group
Group type: EXPERIMENTAL
Intervention: Small changes weight loss program (3-month intervention with bi-weekly phone calls for 6 months)
Number of subjects: 25
Study 20207521 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (100mg/day)
Number of subjects: 72
Study 20207521 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine + Placebo
Number of subjects: 72
Study 17889449 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FACT-H&N score
Number of subjects: 1093
Study 17889449 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional well-being component of FACT-H&N
Number of subjects: 1093
Study 17889449 — intervention group
Group type: COMPARATOR
Intervention: Patients without baseline FACT-H&N data
Number of subjects: 1093
Study 15941977 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of alcohol per day
Number of subjects: 53
Study 15941977 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of alcohol per day
Number of subjects: 53
Study 15941977 — intervention group
Group type: COMPARATOR
Intervention: 0 g of alcohol per day (control)
Number of subjects: 53
Study 12090649 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 24
Study 12090649 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care alone (Control)
Number of subjects: 24
Study 10339777 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate therapy (400 mg/d for 14 days with 76-day intervals, plus 500 mg of supplemental calcium per day)
Number of subjects: 83
Study 10339777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 10339777 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate therapy
Number of subjects: 83
Study 8954030 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg aldosterone iv
Number of subjects: 10
Study 8954030 — intervention group
Group type: COMPARATOR
Intervention: Placebo iv
Number of subjects: 10
Study 1709185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen antigen (Ag)
Number of subjects: 7
Study 1709185 — intervention group
Group type: COMPARATOR
Intervention: Buffer (B) control
Number of subjects: 7
Study 7028051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% ciclopiroxolamine solution
Number of subjects: 0
Study 7028051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% ciclopiroxolamine cream
Number of subjects: 0
Study 7028051 — intervention group
Group type: COMPARATOR
Intervention: 1% tolnaftate solution
Number of subjects: 0
Study 7028051 — intervention group
Group type: COMPARATOR
Intervention: 1% clotrimazole solution
Number of subjects: 0
Study 7028051 — intervention group
Group type: COMPARATOR
Intervention: 1% clotrimazole cream
Number of subjects: 0
Study 30887675 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 102
Study 30887675 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 102
Study 29392984 — intervention group
Group type: EXPERIMENTAL
Intervention: ECAS score
Number of subjects: 5010
Study 26425793 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral transcatheter aortic valve replacement (TF‐TAVR)
Number of subjects: 1521
Study 24812317 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive reappraisal coping intervention (PRCI)
Number of subjects: 377
Study 24812317 — intervention group
Group type: COMPARATOR
Intervention: Emotional monitoring only
Number of subjects: 377
Study 24812317 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 377
Study 22092899 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation
Number of subjects: 107
Study 22092899 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive exam
Number of subjects: 107
Study 22092899 — intervention group
Group type: EXPERIMENTAL
Intervention: Both simulation and cognitive exam
Number of subjects: 107
Study 22092899 — intervention group
Group type: EXPERIMENTAL
Intervention: Passing the cognitive exam
Number of subjects: 107
Study 19458430 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Rivermead Behavioral Memory Test (OL-RBMT)
Number of subjects: 30
Study 17350969 — intervention group
Group type: EXPERIMENTAL
Intervention: esmolol
Number of subjects: 30
Study 17350969 — intervention group
Group type: COMPARATOR
Intervention: remifentanil
Number of subjects: 30
Study 14972467 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein-rich extract (3 capsules daily for 6 months)
Number of subjects: 62
Study 14972467 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance (watchful waiting) subgroup
Number of subjects: 62
Study 11869759 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive cluster (n=22)
Number of subjects: 162
Study 11869759 — intervention group
Group type: EXPERIMENTAL
Intervention: Delusional cluster (n=39)
Number of subjects: 162
Study 11869759 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic cluster (n=72)
Number of subjects: 162
Study 11869759 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritable cluster (n=29)
Number of subjects: 162
Study 9134943 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% penciclovir cream
Number of subjects: 2209
Study 9134943 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control cream
Number of subjects: 2209
Study 8198018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 0
Study 8198018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin with cholestyramine
Number of subjects: 0
Study 10302355 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential protocol using anti-lymphocyte serum (ALS) followed by cyclosporine from the third post-graft month onwards
Number of subjects: 0
Study 10302355 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with ALS alone
Number of subjects: 0
Study 30358132 — intervention group
Group type: EXPERIMENTAL
Intervention: African Dance
Number of subjects: 28
Study 30358132 — intervention group
Group type: COMPARATOR
Intervention: Culture Education
Number of subjects: 28
Study 27052286 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Classroom Instruction (TCI)
Number of subjects: 80
Study 27052286 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Instructed Video (SIV)
Number of subjects: 80
Study 25023098 — intervention group
Group type: COMPARATOR
Intervention: 9 mL agitated saline solution with 1 mL air without the Valsalva maneuver (ASwoVM)
Number of subjects: 330
Study 25023098 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mL agitated saline solution with 1 mL air with the Valsalva maneuver (ASwVM)
Number of subjects: 330
Study 25023098 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mL agitated saline solution, 1 mL air and a drop of the patient's blood without the Valsalva maneuver (ASbwoVM)
Number of subjects: 330
Study 25023098 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mL agitated saline solution, 1 mL air and a drop of the patient's blood, with the Valsalva maneuver (ASbwVM)
Number of subjects: 330
Study 22901712 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided radiofrequency ablation (RFA)
Number of subjects: 44
Study 22901712 — intervention group
Group type: COMPARATOR
Intervention: MR-guided laser ablation (LA)
Number of subjects: 44
Study 20596936 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea filters used in cigarette filters for 2 months
Number of subjects: 0
Study 17825122 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention (educational/CBT workbook, educational visit to consultants, reminder system on medication charts)
Number of subjects: 19
Study 17825122 — intervention group
Group type: COMPARATOR
Intervention: Guidelines alone (control group)
Number of subjects: 19
Study 16107602 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercaloric feeding (1.8-fold of resting energy expenditure)
Number of subjects: 28
Study 16107602 — intervention group
Group type: COMPARATOR
Intervention: Control group (1.2-fold of resting energy expenditure)
Number of subjects: 28
Study 14595609 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training for 6 months
Number of subjects: 52
Study 10227804 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g IVIG/kg/month
Number of subjects: 40
Study 10227804 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g IVIG/kg/month
Number of subjects: 40
Study 10227804 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g iv albumin/kg/month)
Number of subjects: 40
Study 10227804 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 40